Open AccessCorrection: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan
Author(s) -
Hitoshi Tajiri,
Satoshi Motoya,
Fukunori Kinjo,
Atsuo Maemoto,
Takayuki Matsumoto,
Noriko Sato,
Hiroshi Yamada,
Mieko Nagano,
Yutaka Susuta,
Kokoro Ozaki,
Kazuoki Kondo,
Toshifumi Hibi
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0261932
Subject(s) - infliximab , crohn's disease , medicine , crohn disease , open label , inflammatory bowel disease , medline , clinical trial , disease , biology , biochemistry